The Food and Drug Administration (FDA) issued an emergency use authorization for a combination of Bamlanivimab and Etesevimab, a new prophylaxis drug for COVID-19 developed…
![Eli Lilly drug, Bamlanivimab and Etesevimab, approved for COVID care](https://reflector.uindy.edu/wp-content/uploads/2020/03/COVID-Online-header.png)
The Food and Drug Administration (FDA) issued an emergency use authorization for a combination of Bamlanivimab and Etesevimab, a new prophylaxis drug for COVID-19 developed…